{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:55:26Z","timestamp":1792454126557,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s40121-023-00854-6","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T22:01:31Z","timestamp":1693519291000},"page":"2147-2163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort Study"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4833-7118","authenticated-orcid":false,"given":"Davide Fiore","family":"Bavaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Papagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Belati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Diella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Brindicci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2","family":"De Gennaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Gennaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Romanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Stolfa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ronga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pomarico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dell\u2019Aera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Stufano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Dalfino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Saracino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"key":"854_CR1","unstructured":"Antimicrobial resistance surveillance in Europe 2023\u20132021 data. Stockholm: European Centre for Disease Prevention and Control and World Health Organization; 2023. Cataloguing-in-Publication (CIP) data. CIP data are available at http:\/\/apps.who.int\/iris. Accessed 28 May 2023."},{"key":"854_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad100","author":"M Falcone","year":"2023","unstructured":"Falcone M, Tiseo G, Carbonara S, Marino A, Di Caprio G, Carretta A, et al. Mortality attributable to bloodstream infections caused by different carbapenem-resistant gram negative bacilli: results from a nationwide study in Italy (ALARICO Network). Clin Infect Dis. 2023. https:\/\/doi.org\/10.1093\/cid\/ciad100.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"854_CR3","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3390\/antibiotics11081086","volume":"11","author":"D Alrahmany","year":"2022","unstructured":"Alrahmany D, Omar AF, Alreesi A, Harb G, Ghazi IM. Acinetobacter baumannii infection-related mortality in hospitalized patients: risk factors and potential targets for clinical and antimicrobial stewardship interventions. Antibiotics (Basel). 2022;11(8):1086. https:\/\/doi.org\/10.3390\/antibiotics11081086.","journal-title":"Antibiotics (Basel)"},{"key":"854_CR4","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.2147\/IDR.S408927","volume":"16","author":"S Gu","year":"2023","unstructured":"Gu S, Xiong J, Peng S, Hu L, Zhu H, Xiao Y, et al. Assessment of effective antimicrobial regimens and mortality-related risk factors for bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii. Infect Drug Resist. 2023;16:2589\u2013600. https:\/\/doi.org\/10.2147\/IDR.S408927.","journal-title":"Infect Drug Resist"},{"key":"854_CR5","unstructured":"World Health Organization. WHO publishes list of bacteria for which new antibiotics are urgently needed. https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. Accessed 10 May 2023."},{"issue":"4","key":"854_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","volume":"28","author":"M Paul","year":"2022","unstructured":"Paul M, Carrara E, Retamar P, T\u00e4ngd\u00e9n T, Bitterman R, Bonomo RA, et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant gram-negative bacilli (endorsed by European Society of Intensive Care Medicine). Clin Microbiol Infect. 2022;28(4):521\u201347. https:\/\/doi.org\/10.1016\/j.cmi.2021.11.025. (Epub 2021 Dec 16).","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"854_CR7","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1093\/cid\/ciab1013","volume":"74","author":"DT Pranita","year":"2021","unstructured":"Pranita DT, Samuel LA, Robert AB, Amy JM, van David D, Cornelius JC, et al. Infectious Diseases Society of America guidance on the treatment of AmpC \u03b2-lactamase-producing enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia. Infect Clin Infect Dis. 2021;74(12):2089\u2013114. https:\/\/doi.org\/10.1093\/cid\/ciab1013.","journal-title":"Infect Clin Infect Dis"},{"issue":"8","key":"854_CR8","doi-asserted-by":"publisher","first-page":"e0217120","DOI":"10.1128\/AAC.02171-20","volume":"65","author":"EK McCreary","year":"2021","unstructured":"McCreary EK, Heil EL, Tamma PD. New perspectives on antimicrobial agents: cefiderocol. Antimicrob Agents Chemother. 2021;65(8):e0217120. https:\/\/doi.org\/10.1128\/AAC.02171-20. (Epub 2021 Jul 16).","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"854_CR9","doi-asserted-by":"publisher","first-page":"dlab174","DOI":"10.1093\/jacamr\/dlab174","volume":"3","author":"R Pascale","year":"2021","unstructured":"Pascale R, Pasquini Z, Bartoletti M, Caiazzo L, Fornaro G, Bussini L, et al. Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study. JAC Antimicrob Resist. 2021;3(4):dlab174. https:\/\/doi.org\/10.1093\/jacamr\/dlab174.","journal-title":"JAC Antimicrob Resist"},{"issue":"5","key":"854_CR10","doi-asserted-by":"publisher","first-page":"e0214221","DOI":"10.1128\/aac.02142-21","volume":"66","author":"M Falcone","year":"2022","unstructured":"Falcone M, Tiseo G, Leonildi A, Della Sala L, Vecchione A, Barnini S, et al. Cefiderocol-compared to colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2022;66(5):e0214221. https:\/\/doi.org\/10.1128\/aac.02142-21. (Epub 2022 Mar 21).","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"854_CR11","doi-asserted-by":"publisher","first-page":"106825","DOI":"10.1016\/j.ijantimicag.2023.106825","volume":"62","author":"A Russo","year":"2023","unstructured":"Russo A, Bruni A, Gull\u00ec S, Borrazzo C, Quirino A, Lionello R, et al. Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19. Int J Antimicrob Agents. 2023;62(1):106825. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106825.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"854_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S1473-3099(20)30796-9","volume":"21","author":"M Bassetti","year":"2021","unstructured":"Bassetti M, Echols R, Matsunaga Y, Ariyasu M, Dozi Y, Ferrer R, et al. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial. Lancet Infect Dis. 2021;21(2):226\u201340. https:\/\/doi.org\/10.1016\/S1473-3099(20)30796-9. (Epub 2020 Oct 12).","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"854_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S1473-3099(20)30731-3","volume":"21","author":"RG Wunderink","year":"2021","unstructured":"Wunderink RG, Matsunaga Y, Ariyasu M, Clevenbergh P, Echols R, Kaye KS, et al. Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial. Lancet Infect Dis. 2021;21(2):213\u201325. https:\/\/doi.org\/10.1016\/S1473-3099(20)30731-3. (Epub 2020 Oct 12).","journal-title":"Lancet Infect Dis"},{"key":"854_CR14","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/aje\/kwj149","volume":"163","author":"MA Brookhart","year":"2006","unstructured":"Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, St\u00fcrmer T. Variable selection for propensity score models. Am J Epidemiol. 2006;163:1149\u201356.","journal-title":"Am J Epidemiol"},{"key":"854_CR15","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34:3661\u201379.","journal-title":"Stat Med"},{"issue":"6","key":"854_CR16","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s15010-021-01663-0","volume":"49","author":"S Karakonstantis","year":"2021","unstructured":"Karakonstantis S, Kritsotakis EI. Systematic review and meta-analysis of the proportion and associated mortality of polymicrobial (vs monomicrobial) pulmonary and bloodstream infections by Acinetobacter baumannii complex. Infection. 2021;49(6):1149\u201361. https:\/\/doi.org\/10.1007\/s15010-021-01663-0.","journal-title":"Infection"},{"key":"854_CR17","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1093\/jac\/dkz123","volume":"74","author":"T Katsube","year":"2019","unstructured":"Katsube T, Saisho Y, Shimada Y, Furuie H. Intrapulmonary pharmacokinetics of cefiderocol, a novel siderophore cephalosporin, in healthy adult subjects. J Antimicrob Chemother. 2019;74:1971\u20134.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"854_CR18","doi-asserted-by":"publisher","first-page":"e0234722","DOI":"10.1128\/spectrum.02347-22","volume":"10","author":"S Stracquadanio","year":"2022","unstructured":"Stracquadanio S, Bonomo C, Marino A, Bongiorno D, Privitera GF, Bivona DA, et al. Acinetobacter baumannii  and cefiderocol, between cidality and adaptability. Microbiol Spectr. 2022;10(5):e0234722. https:\/\/doi.org\/10.1128\/spectrum.02347-22. (Epub 2022 Sep 29).","journal-title":"Microbiol Spectr"},{"issue":"6","key":"854_CR19","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3390\/antibiotics12061048","volume":"12","author":"L Dalfino","year":"2023","unstructured":"Dalfino L, Stufano M, Bavaro DF, Diella L, Belati A, Stolfa S, et al. Effectiveness of first-line therapy with old and novel antibiotics in ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii: a real life, prospective, observational, single-center study. Antibiotics (Basel). 2023;12(6):1048. https:\/\/doi.org\/10.3390\/antibiotics12061048.","journal-title":"Antibiotics (Basel)"},{"issue":"3","key":"854_CR20","doi-asserted-by":"publisher","first-page":"dlac064","DOI":"10.1093\/jacamr\/dlac064","volume":"4","author":"M Falcone","year":"2022","unstructured":"Falcone M, Suardi LR, Tiseo G, Galfo V, Occhineri S, Verdenelli S, et al. Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study). JAC Antimicrob Resist. 2022;4(3):dlac064. https:\/\/doi.org\/10.1093\/jacamr\/dlac064.","journal-title":"JAC Antimicrob Resist"},{"issue":"10","key":"854_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ofid\/ofac488","volume":"9","author":"DF Bavaro","year":"2022","unstructured":"Bavaro DF, Diella L, Belati A, De Gennaro N, Fiordelisi D, Papagni R, et al. Impact of a multistep bundles intervention in the management and outcome of gram-negative bloodstream infections: a single-center, \u201cproof-of-concept\u201d study. Open Forum Infect Dis. 2022;9(10):4. https:\/\/doi.org\/10.1093\/ofid\/ofac488.","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"854_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.cmi.2016.10.023","volume":"23","author":"PNA Harris","year":"2017","unstructured":"Harris PNA, McNamara JF, Lye DC, Davis JS, Bernard L, Cheng AC, et al. Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition. Clin Microbiol Infect. 2017;23(8):533\u201341. https:\/\/doi.org\/10.1016\/j.cmi.2016.10.023.","journal-title":"Clin Microbiol Infect"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-023-00854-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-023-00854-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-023-00854-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T12:08:30Z","timestamp":1694866110000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-023-00854-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["854"],"URL":"https:\/\/doi.org\/10.1007\/s40121-023-00854-6","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"15 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}